Speaking of SurgOnc

Dr. Rick Greene and Dr. Fadi Dahdaleh discuss the effect of operative approach on overall readiness to commence adjuvant therapy in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy, hypothesizing that minimally invasive pancreaticoduodenectomy improves rates and time to return to intended oncologic therapy compared with open pancreaticoduodenectomy. Dr. Dahdaleh is...

Rick Greene, MD, discusses with Anne O'Shea, MD, and Timothy Vreeland, MD, the role of neoadjuvant chemotherapy or chemoradiation in the treatment of localized pancreatic adenocarcinoma, and the effect of downstaging on overall survival. Dr. O'Shea and Dr. Vreeland are authors of "Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival."...

Rick Greene, MD, Alexandra Gangi, MD, and Rupen Shah, MD, discuss the landmark articles on which management of primary appendiceal peritoneal surface malignancies are based. Drs. Gangi and Shah are authors of, "The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy." Dr. Gangi is Director or the Gastrointestinal Tumor and Cancer Regional Therapies Programs, and Associate Program Di...

Rick Greene, MD, and Samilia Obeng-Gyasi, MD, MPH, discuss the effect of Medicaid expansion under the Affordable Care Act on patterns of surgical care among low-income breast cancer patients. Dr. Obeng-Gyasi is author of " Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients? " Dr. Obeng-Gyasi is Assistant Professor of Surgery in the Division of Surgic...

Rick Greene, MD, and Mark Truty, MD, discuss the role of neoadjuvant chemotherapy in the treatment of pancreatic cancer, including the optimal treatment of patients who do not respond to first-line chemotherapy or develop toxicities. Dr. Truty is author of, "Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer." Dr. Truty is Associate Professor of Surgery, Ma...

Rick Greene, MD, and Adam Berger, MD, discuss a shift away from nonurgent and preventative medical care due to the pandemic, related changes in presentation of melanoma patients in surgical clinics, and the likely impact on melanoma diagnoses and prognoses. Dr. Berger is author of, "COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States." Dr. Be...

Rick Greene, MD, and Nicole Lopez, MD, discuss a watch and wait approach to treating rectal cancer with complete clinical response after neoadjuvant therapy, which reduces overall costs and increases effectiveness compared with radical resection. Dr. Lopez is author of, "Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant C...

In this episode of Speaking of SurgOnc, Rick Greene, MD, and Mary Gemignani, MD, discuss quality of life outcomes associated with surgical management of early-stage breast cancer. Dr. Gemignani is author of the article, "A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction." Dr. Gemignani is Professor of Surgery, Weill Cornell...

In this episode of Speaking of SurgOnc, Rick Greene, MD and Lesly A. Dossett, MD, discuss meeting the needs of an increasingly culturally and racially diverse patient population, as well as support and recruitment of a surgical oncology workforce that better represents all minority groups. Dr. Dossett is author of the article, "Cultural Complications Curriculum: Applicability to Surgical Oncology...

In this episode of Speaking of SurgOnc, Rick Greene, MD and Jonathan M. Hernandez, MD, discuss the need for surgical oncologists to keep informed of ongoing research in multiple arenas and the launch of a new editorial series to address current challenges in meeting this need. Dr. Hernandez is author of the editorial, "Introducing the Ongoing Clinical Trials in the Surgical Oncology Series." Dr. H...

In this episode of Speaking of SurgOnc, Rick Greene, MD and John H. Stewart, MD, discuss the unequal burden of melanoma between Blacks and whites in the United States and the differences in access to melanoma care. Dr. Stewart is author of the article, "Landmark Series on Disparities in Surgical Oncology: Melanoma." Dr. Stewart is Professor of Surgery, LSU Health New Orleans School of Medicine, an...

In this episode of Speaking of SurgOnc, Rick Greene, MD and Kristin E. Rojas, MD, discuss the implementation of an opioid-sparing multimodal analgesia protocol for lumpectomy patients for pain management without a routine opioid prescription. Dr. Rojas is author of the article, "Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control." Dr...

In this episode of Speaking of SurgOnc ®, Rick Greene, MD, and Judy Boughey, MD, discuss the impact of COVID-19 on US clinical research at the local, cooperative group, and national level. Dr. Boughey is the author of the article, "Impact of the COVID-19 Pandemic on Cancer Clinical Trials." Dr. Judy Boughey is Professor of Surgery in Division of Breast and Melanoma Surgical Oncology, Department of...

Rick Greene, MD, and Elisa Port, MD, discuss surgeon adherence to NCCN guidelines and patterns of testing in newly diagnosed breast cancer patients. Dr. Port is author of, "Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?" Dr. Port is Chief of Breast Surgery and Director of the Dubin Breast Center, Mount Sinai Hospital, and  Professor of Surgery, Icah...

Rick Greene, MD and Nancy Cho, MD discuss the impact of the 2015 American Thyroid Association guideline change on clinical practice in low-risk differentiated thyroid cancer, specifically regarding the rate of completion thyroidectomy. Dr. Cho is author of the article, "Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines." Dr. Cho is Associate Sur...

Rick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatment with parathyroidectomy. Dr. Balentine is author of, "Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons." Dr. Balentine is Assistant Professor of General and Endocrine Surge...

Rick Greene, MD and Vivian Strong, MD discuss factors associated with quality-of-life recovery after gastrectomy. Dr. Strong is author of "Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer." Dr. Strong is the Iris Cantor Endowed Chair and Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery and Associate Dean, Weill Cornell Medical College of...

Rick Greene, MD, and Melissa Hogg, MD, discuss the relationship of serum CA19-9 to other markers of response, and the related thresholds correlating to outcomes, following neoadjuvant therapy for pancreatic adenocarcinoma. Dr. Hogg is author of the article, "Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma." Dr. Hogg is the Direct...

Rick Greene, MD, and Ken Tanabe, MD, discuss the need for surgical oncologists to remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic continues to impose. Dr. Tanabe is author of, "Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change." Dr. Tanabe is a Professor of Surgery...

Rick Greene, MD and Charlotte Ariyan, MD, PhD, discuss survival outcomes in patients with metastatic melanoma who were selected for surgery following checkpoint blockade. Dr. Ariyan is author of, "Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade." Dr. Ariyan is Associate Professor of Surgery, Weill Cornell Medical College, and a Surgeon wit...

Rick Greene, MD and Katie Egan, MD discuss the use of an educational intervention to decrease opioid consumption among breast surgery patients. Dr. Egan is author of the article, " Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial ." Dr. Egan is Plastic and Reconstructive Surgery Resident at The University of Kansas Medical...

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of " The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer." Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.

Rick Greene, MD, and Alexandra Gangi, MD and James Howe, MD, discuss current data regarding management of neuroendocrine liver metastases and future areas for study. Dr. Gangi and Dr. Howe are authors of " The Landmark Series: Neuroendocrine Tumor Liver Metastases." Dr. Gangi is Assistant Professor of Surgery in the Department of Surgical Oncology and the Director of the Gastrointestinal Tumor Pro...

Rick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, " Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies ." Dr. Karakousis is Associate Prof...

Rick Greene, MD, and Michael D'Angelica, MD discuss the relationship between hepatic parenchymal disease and recurrence after colorectal liver metastases resection, which has not been well defined. Dr. D'Angelica is author of, " Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases ." Dr. D'Angelica holds the Enid A. Haupt Chair in Surger...